fbpx

Latest sensyne publications


Sensyne Health partners with Bayer to develop treatment for heart disease using AI

UK clinical healthcare disruptor signs first major drug development deal since IPO Sensyne Health has struck a two year deal with pharmaceutical giant Bayer to develop new treatments for cardiovascular disease using Sensyne’s AI technology. The NHS Long Term Plan has identified the prevention of cardiovascular disease, which currently affects 7 million people in the… Read More



Do NOT follow this link or you will be banned from the site!